Journals / Klinik Psikofarmakoloji Bülteni / 2012 / Cilt: 22 - Sayı: 3

Olanzapin kullanımına bağlı gelişen bir geç diskinezi olgusu

A case of tardive dyskinesia due to olanzapine treatment

Pages
268–270
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, a case of tardive dyskinesia due to olanzapine use in a 24 year-old male patient is discussed in the light of existing literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Tardive dyskinesia (TD) is a complex of abnormal reflex movements involving the tongue, body, arms, and legs after the use of antipsychotics.
📊
Key Findings & Data:According to the DSM-IV, these reflex movements must have been present for at least four weeks and the antipsychotic medication should have been used for at least 3 months (at least 1 month if the patient is 60 years or older) for the TD to have been caused by the use of antipsychotic drugs.
💡
Conclusion & Impact:In this report, a case of tardive dyskinesia due to olanzapine use in a 24 year-old male patient is discussed in the light of existing literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Tardive dyskinesia (TD) is a complex of abnormal reflex movements involving the tongue, body, arms, and legs after the use of antipsychotics. These movements are generally choreiform, athetoid, or rhythmic. According to the DSM-IV, these reflex movements must have been present for at least four weeks and the antipsychotic medication should have been used for at least 3 months (at least 1 month if the patient is 60 years or older) for the TD to have been caused by the use of antipsychotic drugs. TD development is much more common with the use of high potency classic antipsychotics that block dopamine receptors in the nigrostriatal area and the risk increases as the dosage increases. Atypical antipsychotics such as risperidone, olanzapine, quetiapine, and ziprasidone have lower risks for TD development. Olanzapine has been used in the treatment of cases where tardive dyskinesia occurred due to other psychotropic medications and there are rare case reports about olanzapine caused tardive dyskinesia. In this report, a case of tardive dyskinesia due to olanzapine use in a 24 year-old male patient is discussed in the light of existing literature.

Özet

Geç diskinezi (GD) , antipsikotik kullanımı sonrasında dilde, çenede, gövdede, kol ve bacaklarda ortaya çıkan anormal istemsiz hareketler kompleksidir. Bu hareketler çoğunlukla koreiform, atetoid veya ritmik hareketlerdir. Antipsikotik kullanımının neden olduğu GD tanısı için, DSM-IV ölçütlerine göre, bu istemsiz hareketlerin en az 4 hafta süreyle var olması, antipsikotik ilacın en az 3 ay, eğer 60 yaş ve üstünde ise en az 1 ay süre ile kullanılması gerekmektedir. Nigro-striatal bölgedeki dopamin reseptörlerini bloke eden yüksek potensli klasik antipsikotiklerin kullanımı ile GD gelişimi daha fazladır ve doz arttıkça risk artmaktadır. Risperidon, olanzapin, ketiapin, ziprasidon gibi atipik antipsikotikler daha düşük GD gelişimi riskine sahiptir. Olanzapin, diğer psikotrop ilaçlara bağlı gelişen geç diskinezi olgularının tedavisinde kullanılmaktadır ve geç diskineziye yol açtığı ile ilgili olgu sunumları nadirdir. Bu yazıda, mevcut literatür ışığında 24 yaşında erkek bir hastada olanzapin kullanımına bağlı gelişen geç diskinezi tartışılmıştır.

🔖

Cite This Article

GÜNAY, H., BİLGEN, A. E., ZİNCİR, S., ERDEM, M., BOZKURT, A. (2022). Olanzapin kullanımına bağlı gelişen bir geç diskinezi olgusu. Klinik Psikofarmakoloji Bülteni, Cilt: 22 - Sayı: 3, 268–270. https://ajindex.com/articles/574098

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Woerner MG, Alvir JM, Saltz BL, Lieberman JA, Kane JM. Prospective study of tardive dyskinesia in the elderly: rates and risk factors. Am J Psychiatry 1998;155(11):1521-8
  2. Morgenstern H, Glazer WM. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Arch Gen Psychiatry 1993; 50(9):723-33
  3. Gupta S, Mosnik D, Black WD, Berry S, Masand PS. Tardive dyskinesia: review of treatments past, present and future. Ann Clin Psychiatry 1999;11(4):257-66
  4. Haberfellner EM. Remission of tardive dyskinesia after changing from flupenthixol to olanzapine. Eur Psychiatry 2000; 15(5):338-9
  5. Soutullo CA, Keck PE Jr, McElroy SL. Olanzapine in the treatment of tardive dyskinesia: a report of two cases. J Clin Psychopharmacol 1999;19(1):100-1
  6. Almeida OP. Olanzapine for the treatment of tardive dyskinesia. J Clin Psychiatry 1998;59(7):380-1
  7. Breier A, Hamilton SH. Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia. Biol Psychiatry 1999;45(4):403-11
  8. Owens DGC. Tardive dyskinesia. In: A Guide to the Extrapyramidal Side-effects of Antipsychotic Drugs. Cambridge, UK: Cambridge Üniversity Press 1999:166-226
  9. Lu LM, Lane HY. Olanzapine-induced tardive dyskinesia. BMJ 2003;182(1):81-2
  10. Conley RR, Meltzer HY. Adverse events related to olanzapine. J Clin Psychiatry 2000;61 (Suppl.8):S26-S9
  11. Dunayevich E, Strakowski SM. Olanzapine-induced tardive dystonia. Am J Psychiatry 1999; 156(10):1662
  12. Caykoylu A, Aydin N, Karalar F. Atipik antipsikotiklerle ortaya çıkan bir geç diskinezi ve süpersensitivite psikozu olgusu. Klinik Psikofarmakoloji Bülteni - Bulletin of Clinical Psychopharmacology 2001;11(1):37-40 (Turkish).